KORU Medical Systems, Inc.
KRMD
$3.83
-$0.07-1.80%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 7.98% | 4.74% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.98% | 4.74% | |||
| Cost of Revenue | 11.17% | -1.44% | |||
| Gross Profit | 6.07% | 8.82% | |||
| SG&A Expenses | 8.97% | 0.77% | |||
| Depreciation & Amortization | 10.21% | -12.37% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.37% | 1.53% | |||
| Operating Income | -58.09% | 36.95% | |||
| Income Before Tax | -67.38% | 38.03% | |||
| Income Tax Expenses | -- | 2,450.00% | |||
| Earnings from Continuing Operations | -65.76% | 37.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -65.76% | 37.42% | |||
| EBIT | -58.09% | 36.95% | |||
| EBITDA | -37.38% | 26.75% | |||
| EPS Basic | -65.71% | 37.50% | |||
| Normalized Basic EPS | -67.69% | 38.10% | |||
| EPS Diluted | -29.85% | 20.24% | |||
| Normalized Diluted EPS | -67.69% | 38.10% | |||
| Average Basic Shares Outstanding | 0.08% | 0.19% | |||
| Average Diluted Shares Outstanding | 0.08% | 0.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||